Cefidero Sulfate Injection (FETROJA) Drug Encyclopedia and Current Marketing Status in China

Cefideril sulfate injection (FETROJA) is an innovative cephalosporin antibiotic developed by Japan's Shionogi Pharmaceutical Co., Ltd. Its active ingredient is Cefiderocol, which has a unique siderophore function and can penetrate the cell membrane of Gram-negative bacteria, overcome multiple drug resistance mechanisms, and show strong antibacterial activity against multi-drug resistant bacteria. The drug is mainly used to treat complicated urinary tract infections (cUTI), hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by sensitive Gram-negative microorganisms.

Cefideril sulfate injection has achieved remarkable results in foreign markets. In November 2019, the U.S. Food and Drug Administration (FDA) approved the drug for the treatment of cUTI in adult patients. Subsequently, in 2020, the European Medicines Agency (EMA) also approved its marketing application. In addition, the drug has been granted multiple qualifications, including FDA's Qualified Anti-Infectious Drug (QIDP) qualification and Fast Track qualification, as well as EMA's Accelerated Assessment qualification, which all reflect its important status in the field of anti-infective treatment.

In the Chinese market, cefideril sulfate injection has not yet been officially launched, but it has attracted widespread attention. With the increasing domestic demand for new antibiotics and the successful application of the drug in foreign markets, its domestic launch process has attracted much attention. It is understood that the drug is currently in the clinical trial stage, and relevant research results are expected to provide new options for anti-infective treatment in China.

It is worth noting that although cefideril sulfate injection has significant antibacterial activity, its use must still be strictly followed by medical instructions. Before taking medication, patients should inform their doctor in detail about their allergies, disease history, and other medications they are taking to ensure the safety of medication. At the same time, doctors should also formulate a reasonable medication plan based on the patient's specific situation and closely monitor changes in the patient's condition.

In summary, cefideril sulfate injection, as an innovative antibiotic drug, has achieved remarkable results in foreign markets and is expected to provide new treatment options for patients in the Chinese market. However, its use still requires caution to ensure drug safety and efficacy.

Reference materials:https://www.drugs.com/pro/fetroja.html#S5.1